Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Perrigo Company plc (PRGO)

  • Business News
  • Jan. 14, 2026, 17:00 UTC
  • 7
  • 1 comments

Deadline Alert: Perrigo Company plc (PRGO) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Market reaction Comment Full text

Smart for Life, Inc. (SMFL)

  • Business News
  • Jan. 14, 2026, 16:36 UTC
  • 6
  • 1 comments

STEM Literacy Project Expands Across North Carolina Collegiate SWE Sections

Market reaction Comment Full text

Cosmos Holdings Inc. (COSM)

  • Business News
  • Jan. 14, 2026, 16:25 UTC
  • 3
  • 1 comments

Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research

Market reaction Comment Full text

BridgeBio Pharma (BBIO)

  • Business News
  • Jan. 14, 2026, 15:14 UTC
  • 3
  • 1 comments

BridgeBio Continues Long Term Debt Management Strategy and Announces Proposed Offering of Convertible Senior Notes Due 2033 to Prefund Repayment of Convertible Senior Notes Due 2027

Market reaction Comment Full text

Mainz Biomed (MYNZ)

  • Business News
  • Jan. 14, 2026, 14:29 UTC
  • 4
  • 1 comments

Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting

Market reaction Comment Full text

Oncolytics Biotech Inc (ONCY)

  • Business News
  • Jan. 14, 2026, 14:12 UTC
  • 5
  • 1 comments

A New Press Release from Oncolytics Biotech, Inc

Market reaction Comment Full text

Femasys Inc (FEMY)

  • Business News
  • Jan. 14, 2026, 14:02 UTC
  • 5
  • 1 comments

- Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement

Market reaction Comment Full text

Nexalin Technology Inc (NXLIW)

  • Business News
  • Jan. 14, 2026, 14:00 UTC
  • 4
  • 1 comments

Published Peer-Reviewed Study Demonstrates NexalinsDIFS™ Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD

Market reaction Comment Full text

Adial Pharmaceuticals Inc (ADIL)

  • Business News
  • Jan. 14, 2026, 14:00 UTC
  • 3
  • 1 comments

Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045

Market reaction Comment Full text

Nexalin Technology Inc (NXLIW)

  • Business News
  • Jan. 14, 2026, 14:00 UTC
  • 5
  • 1 comments

Published Peer-Reviewed Study Demonstrates Nexalin’s DIFS™ Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD

Market reaction Comment Full text
  • Previous
  • 56
  • 57
  • 58
  • 59
  • 60
  • Next

Search

News categories

  • Technical Exchange News(10849)
  • Event(2223)
  • SEC News(187894)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124366)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin